肝血管肉瘤在PET/CT上表现为弥漫性18F-FDG摄取增高
Hepatic Angiosarcoma With Diffuse Increased 18 F-FDG Uptake on PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-04-27
一名51岁女性因实验室指标诊断为暴发性肝衰竭,增强CT显示肝脏各段弥漫性多发灶,18F-FDG PET/CT显示肿大肝脏内大量局灶性18F-FDG摄取增高,因暴发性肝衰竭行肝移植,术后病理证实为弥漫性肝血管肉瘤,提示该病应纳入PET/CT上肝脏弥漫性18F-FDG摄取增高病变的鉴别诊断。
要点
- 51岁女性暴发性肝衰竭患者,增强CT见肝脏各段弥漫多发灶。
- 18F-FDG PET/CT显示肿大肝脏内大量局灶性18F-FDG摄取增高。
- 术后病理证实为弥漫性肝血管肉瘤,应纳入弥漫性FDG摄取增高肝病变的鉴别诊断。
核心结论
- 术后病理证实为弥漫性肝血管肉瘤,该病应纳入PET/CT上肝脏弥漫性18F-FDG摄取增高病变的鉴别诊断。
研究设计与样本
- 病例报告:一名51岁女性,基于实验室指标诊断为暴发性肝衰竭,行增强CT和18F-FDG PET/CT检查,因暴发性肝衰竭行肝移植,术后病理确诊。
主要发现
- 增强CT显示肝脏所有段内大量、广泛分布的病灶。
- 18F-FDG PET/CT显示肿大肝脏内大量局灶性18F-FDG摄取增高。
- 因暴发性肝衰竭行肝移植,术后病理显示弥漫性肝血管肉瘤。
关键数值与推荐
- 18F-FDG PET/CT显示肿大肝脏内大量局灶性18F-FDG摄取增高。
临床怎么用
- 作者认为,弥漫性肝血管肉瘤应纳入PET/CT上肝脏弥漫性18F-FDG摄取增高病变的鉴别诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 51-year-old woman was diagnosed with fulminant hepatic failure based on laboratory indexes. Contrast-enhanced CT demonstrated numerous, widespread lesions in all segments of the liver. 18 F-FDG PET/CT showed the abundant foci of increased 18 F-FDG uptake in the enlarged liver. The liver transplantation was performed due to fulminant hepatic failure. Postoperative pathology demonstrated diffused hepatic angiosarcoma, which should be included in the differential diagnosis of diffuse 18 F-FDG uptake hepatic lesions on PET/CT.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Zhou Z, Lu X, Wang W, et al. Hepatic Angiosarcoma With Diffuse Increased 18 F-FDG Uptake on PET/CT. Clin Nucl Med. 2022. PMID: 35383600. doi:10.1097/RLU.0000000000004152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。